Tech Company Financing Transactions

MSICS Pharma Funding Round

On 5/3/2026, MSICS Pharma raised $3.6 million in funding from Fusion Fund, GlenRock Israel and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Ness Ziona, Undisclosed
Israel

Phone

Undisclosed

Website

www.msicspharma.com

Email Address

[email protected]

Overview

MISSION: A new era of medicine; To revolutionize global mental healthcare, we harness the power of naturally-sourced Psilocybin, producing cutting-edge products tailored for pharmaceutical applications, to effectively address the world's pressing health needs. MSICS operates an innovative GMP production facility producing MSX-06 - MSICS's flagship naturally-sourced Psilocybin product.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Roei Zerahia

        

VP - Bus. Development

Omer Zerahia

        

Browse more venture capital transactions:

Prev: 5/1/2026: Nura Studios venture capital transaction
Next: 5/3/2026: OTee venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary